Transplantation of human iPS cell-derived glial-rich neural progenitor cells into ALS model mice extends their lifespans

July 7, 2014
Transplantation of human iPS cell-derived glial-rich neural progenitor cells into ALS model mice extends their lifespans
Fig:hiPSC-GRNPs transplantation improved survival in ALS model mice. Survival (Kaplan-Meier plot) analysis shows a significant difference between the PBS injection group (black line) survival and the hiPSC-GRNPs transplantation group (green line) survival throughout the course of the study (n=21 mice per group, P=0.00691 stratified long-rank test), suggesting that the hiPSC-GRNPs transplantation group had better survival (**p< 0.01).

A research group led by Dr. Haruhisa Inoue, Professor of the Center for iPS Cell Research and Application (CiRA), Kyoto University, and Researcher Dr. Takayuki Kondo of CiRA discovered that the transplantation of human iPS cell-derived glial-rich neural progenitor cells into amyotrophic lateral sclerosis (ALS) model mice extended their lifespans.

It is known that the transplantation of mouse and human fetus derived into the SOD1 gene mutation-induced ALS model mice delays the degeneration of and pathological progression. To apply this to clinical cases, it was necessary to perform studies with human cells that can be continuously supplied.

Inoue's group established a differentiation protocol of glial-rich neural progenitor cells, which are neuronal precursors of the glial lineage, from human iPS cells and transplanted them into the lumbar cord of the ALS model mice. The transplanted cells differentiated into astrocytes, and the survival time of mice with the graft was extended compared to that of those without the graft. It was also suggested that the transplanted cells improve the spinal cord environment by increasing neurotrophic factors. These findings suggest the possibility of treating ALS patients with cell transplantation using human iPS cells.

ALS is a progressive disease in which motor neurons become dysfunctional and muscles become unable to move. Studies on the treatment of ALS are roughly divided into 2 strategies. One is to reproduce the pathology of ALS and search for a therapeutic drug to improve it. The other is the complementation and regeneration of motor neurons with ALS, which have lost their function to appropriately stimulate muscle, by cell transplantation. Employing the latter strategy, the research team reported that therapeutic effects, including extension of the survival time, can be expected to some extent through the transplantation of the human iPS cell-derived glial-rich neural (hiPSC-GRNPs), many of which differentiated into astrocytes after transplantation.

Neurotrophic factor is important in the pathology of ALS, and it is being investigated worldwide as a target of treatment. Inoue's study demonstrated that neurotrophic factor increased with the treatment and that the spinal cord environment in the ALS model mice was improved.

Cells of the glial lineage have a function to prepare the environment around nerve cells. Assuming that healthy motor neurons are flowering plants, cells of the glial lineage play the role of the soil supplying nutrients required for the flowers to bloom. However, it is difficult to replant withering plants, i.e., regenerate lost motor neurons. In this study, the team started by supplementing with good soil, which are human iPS cell-derived glial-rich neural progenitors. In order to regenerate diseased motor neurons, it is necessary not only to supply good soil but also to replant plants themselves. In the future, the transplantation of healthy motor neurons may more efficiently recover the function, but many issues remain to be overcome, and a lot of time is necessary before reaching the stage of investigating the therapeutic effects in humans.

Explore further: Cell scientists slow degeneration in motor neurone mice

More information: "Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice." Takayuki Kondo, Misato Funayama, Kayoko Tsukita, Akitsu Hotta, Akimasa Yasuda, Satoshi Nori, Shinjiro Kaneko, Masaya Nakamura, Ryosuke Takahashi, Hideyuki Okano, Shinya Yamanaka, Haruhisa Inoue. Stem Cell Reports (2014) DOI: dx.doi.org/10.1016/j.stemcr.2014.05.017

Related Stories

Cell scientists slow degeneration in motor neurone mice

June 27, 2014
Japanese stemcell scientists have succeeded in slowing the deterioration of mice with motor neurone disease, possibly paving the way for eventual human treatment, according to a new paper.

Team finds a better way to grow motor neurons from stem cells

April 1, 2014
Researchers report they can generate human motor neurons from stem cells much more quickly and efficiently than previous methods allowed. The finding, described in Nature Communications, will aid efforts to model human motor ...

Stem cell-based transplantation approach improves recovery from stroke

June 19, 2014
Stroke is a leading cause of death and disability in developed countries, and there is an urgent need for more clinically effective treatments. A study published by Cell Press June 19th in Stem Cell Reports reveals that simultaneous ...

Autologous transplantation shows promising results for iPS cell therapy in Parkinson's disease

September 26, 2013
A research team led by Professor Jun Takahashi and Assistant Professor Asuka Morizane at the Center for iPS Cell Research and Application (CiRA) at Kyoto University, Japan, has carried out a study to compare the impact of ...

Transplanted neural stem cells treat ALS in mouse model

December 19, 2012
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is untreatable and fatal. Nerve cells in the spinal cord die, eventually taking away a person's ability to move or even breathe. A consortium of ALS ...

Recommended for you

Brain cells found to control aging

July 26, 2017
Scientists at Albert Einstein College of Medicine have found that stem cells in the brain's hypothalamus govern how fast aging occurs in the body. The finding, made in mice, could lead to new strategies for warding off age-related ...

Post-stroke patients reach terra firma with new exosuit technology

July 26, 2017
Upright walking on two legs is a defining trait in humans, enabling them to move very efficiently throughout their environment. This can all change in the blink of an eye when a stroke occurs. In about 80% of patients post-stroke, ...

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

New vaccine production could improve flu shot accuracy

July 24, 2017
A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.